ropinirole

(redirected from Requip)
Also found in: Medical.
Related to Requip: Restless Leg Syndrome, Requip XL

ro·pin·i·role

 (rō-pĭn′ə-rōl′)
n.
A dopamine agonist, C16H24N2O, used in its hydrochloride form to treat Parkinson's disease and restless legs syndrome.

[(p)rop(yl) + (am)in(o) + -ir- (probably alteration of (h)y(d)r(o)-) + (ind)ole.]
Translations

ropinirole

n ropinirol m
References in periodicals archive ?
He listed initiatives, including the requirements of TEEP that is forcing all local authorities to review their collection systems and assess the environmental benefits derived from them; the MRF Code of Practice aimed at improving material yield and quality from primary treatment plants; ReQuip the Resource Association's quality standard for raw material supply into UK reprocessing plants and the Recyclass Tool for improving packaging design for recycling.
Requip and Mirapex are oral medications approved by the FDA for the treatment of RLS and are typically administered daily before bedtime but can also have a split dosage time with part of the dose in the late afternoon/early evening and the other at bedtime.
Prescribed drug ReQuip is taken to alleviate symptoms of the nervous system disorder, which causes shaking.
All the complaints under a "yellow card" scheme run by the Medicines and Healthcare Products Regulatory Agency came from patients who took Ropinirole, known by the trade name ReQuip.
In a landmark ruling, GSK was ordered to pay damages of E400,000 ([pounds sterling]160,000) to Didier Jambart, who began taking Requip in 2003.
Vicki had eight weeks off work and started taking ReQuip, a drug to control the symptoms and slow the condition.
In October 2004 his doctor prescribed an alternative dopamine agonist, Requip.